Innovotech Inc.

Innovotech Inc.

December 22, 2008 18:29 ET

Innovotech Inc. Announces Amendment to Warrant Terms

EDMONTON, ALBERTA--(Marketwire - Dec. 22, 2008) - Innovotech Inc. (TSX VENTURE:IOT) today announced that it has applied to the TSX Venture Exchange for a two (2) month extension in the expiry date of common share purchase warrants (the "Warrants") from December 27, 2008 to February 28, 2009. The Warrants currently have an exercise price of $0.75 and were issued in connection with a private placement of an aggregate of 3,000,000 units at $0.60 per unit that closed on December 27, 2007. In all other respects, the terms of the Warrants will remain unchanged and in full force and effect.

About Innovotech Inc:

Innovotech is a product development company focusing on the development of solutions to medical, agricultural and industrial problems caused by microbial biofilms. Biofilms are protected communities of microorganisms which are very common and very difficult to treat due to their inherent resistance. They have been implicated in a host of devastating infections in agriculture, human health and industry. No diagnostics or antibiotics are currently approved for use in infections involving biofilms.

This document contains forward-looking statements that are predictive in nature and subject to risks and uncertainties that cannot be predicted or quantified; consequently, actual results may differ materially from past results and those expressed or implied by any forward-looking statements. Factors that could cause or contribute to such risks or uncertainties include, but are not limited to: the regulatory environment including the difficulty of predicting regulatory outcomes; changes in the value of the Canadian dollar; the Company's reliance on a small number of customers including government organizations; fluctuations in operating results; government policies or actions; progress and cost of clinical trials; reliance on key strategic relationships; uncertainty related to intellectual property protection and potential costs associated with its defense; the Company's exposure to lawsuits and other matters beyond the control of management. Should known or unknown risks or uncertainties materialize, or should management's assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly make or update any forward-looking statements, except as required by applicable law. There is no assurance that unexercised warrants will be exercised.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information